Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, and Town Hall Ventures. Learn more at aetion.com, follow us at @aetioninc, and subscribe to our monthly newsletter, The Evidence Digest, at https://www.aetion.com/evidence-digest.
Total Funding: $96.3 M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2B
Company Size: 101 to 250
Founded: 2015
May 2020
- Partnership: FDA Partners with Aetion to Gather Real-World Data on the Coronavirus
Apr 2020
- Product Launch: Aetion, HealthVerity Launch New Tools for Assessing COVID-19 Treatments
May 2019
- Awards/Accolades: Aetion Presentation Awarded ?Best Podium? at ISPOR 2019
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Aetion
Engagement Manager
New York, New York
Senior Scientist (Epidemiology)
New York, New York
Scientist (Epidemiology)
New York, New York
Science Prospects
New York, New York
Director, Science
New York, New York
Aetion - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Aetion - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started